Search Results - "Zapata, Nidia Paulina"
-
1
First Time Mexican Report of Next Gene Sequencing (NGS) Panel in Newly Diagnose Acute Myeloid Leukemia (AML). Series of Cases
Published in Blood (02-11-2023)“…Background: Acute Myeloid Leukemia a heterogeneous disease. Molecular alterations were described since 2010, and the combination of them have led to predict a…”
Get full text
Journal Article -
2
Inferior Outcome in Non-Adult Young Adolescent B-Cell Acute Lymphoblastic Leukemia Exhibiting Obesity
Published in Blood (15-11-2022)Get full text
Journal Article -
3
P-147 Central Nervous System Involvement in Multiple Myeloma Cases Reported at Instituto Nacional de Cancerología
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
4
Predictive Ability of Coronary Artery Disease on Age Acceleration and Clinical Outcome in Adult Acute Myelogenous Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
5
Phase Angle and Body Composition As a Prognostic Factor in Acute Lymphoblastic Leukemia
Published in Blood (02-11-2023)“…Acute lymphoblastic leukaemia (ALL) is a malignant proliferation of lymphoid cells blocked at an early stage of differentiation that can invade bone marrow,…”
Get full text
Journal Article -
6
Hematopoietic Cell Transplantation in First Remission in AML in Mexico: Very Low Rates Derived from Early Relapses and Lack of Access
Published in Blood (15-11-2022)Get full text
Journal Article -
7
Understanding factors limiting hematopoietic cell transplantation for acute myeloid leukemia patients in Mexico: a comprehensive analysis
Published in Annals of hematology (01-10-2024)“…Acute myeloid leukemia (AML) is the most frequent indication for allogeneic hematopoietic cell transplantation (alloHCT) worldwide; social and health system…”
Get full text
Journal Article -
8
-
9
MDS-460 Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…High-risk myelodysplastic syndromes (HR-MDS), identified by an IPSS-R score >3.5, have an increased risk of progressing to acute myeloid leukemia. The standard…”
Get full text
Journal Article